SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 145 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,152,070 | -42.0% | 49,830 | -34.2% | 0.00% | – |
| Q2 2023 | $1,985,510 | -64.7% | 75,725 | -65.4% | 0.00% | -100.0% |
| Q1 2023 | $5,625,451 | +22.8% | 218,549 | +24.1% | 0.00% | 0.0% |
| Q4 2022 | $4,581,662 | -30.7% | 176,150 | -23.9% | 0.00% | -50.0% |
| Q3 2022 | $6,607,000 | +207.2% | 231,558 | +165.0% | 0.00% | – |
| Q2 2022 | $2,151,000 | -86.2% | 87,368 | -68.4% | 0.00% | -100.0% |
| Q1 2022 | $15,610,000 | +188.4% | 276,593 | +216.7% | 0.00% | – |
| Q4 2021 | $5,412,000 | +188.9% | 87,336 | +195.8% | 0.00% | – |
| Q3 2021 | $1,873,000 | +60.9% | 29,524 | +109.1% | 0.00% | – |
| Q2 2021 | $1,164,000 | -0.2% | 14,119 | -10.9% | 0.00% | – |
| Q1 2021 | $1,166,000 | -38.0% | 15,849 | -38.9% | 0.00% | – |
| Q4 2020 | $1,882,000 | +503.2% | 25,942 | +80.3% | 0.00% | – |
| Q3 2019 | $312,000 | – | 14,392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |